Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 2.00 | 117.50 | 0.0170 | -0.7261 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 115.00 | 117.50 | 0.9787 | 0.9791 | |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 156.25 | 28.40 | 60.00 | 117.50 | 0.5106 | 0.4407 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 156.25 | 28.40 | 74.00 | 117.50 | 0.6298 | 0.5960 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 156.25 | 28.40 | 55.00 | 117.50 | 0.4681 | 0.3808 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 156.25 | 28.40 | 157.00 | 117.50 | 1.3362 | 1.3039 |
| BT-20 | Erlotinib | 1 | uM | 7 | 156.25 | 28.40 | 146.00 | 117.50 | 1.2426 | 1.2236 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 109.00 | 117.50 | 0.9277 | 0.9280 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 103.00 | 117.50 | 0.8766 | 0.8755 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 156.25 | 28.40 | 69.00 | 117.50 | 0.5872 | 0.5424 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 156.25 | 28.40 | 116.00 | 117.50 | 0.9872 | 0.9875 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 75.00 | 117.50 | 0.6383 | 0.6065 | |
| BT-20 | Linsitinib | 0.1 | uM | 7 | 156.25 | 28.40 | 133.00 | 117.50 | 1.1319 | 1.1247 |
| BT-20 | Lapatinib | 0.0016596 | uM | 7 | 156.25 | 28.40 | 143.00 | 117.50 | 1.2170 | 1.2012 |
| BT-20 | Lapatinib | 0.0033113 | uM | 7 | 156.25 | 28.40 | 120.00 | 117.50 | 1.0213 | 1.0207 |
| BT-20 | Linsitinib | 1 | uM | 7 | 156.25 | 28.40 | 127.00 | 117.50 | 1.0809 | 1.0774 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 156.25 | 28.40 | 130.00 | 117.50 | 1.1064 | 1.1012 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 156.25 | 28.40 | 112.00 | 117.50 | 0.9532 | 0.9538 |
| BT-20 | 17-AAG | 1 | uM | 7 | 156.25 | 28.40 | 57.00 | 117.50 | 0.4851 | 0.4051 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 130.00 | 117.50 | 1.1064 | 1.1012 | |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 156.25 | 28.40 | 151.00 | 117.50 | 1.2851 | 1.2605 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 156.25 | 28.40 | 93.00 | 117.50 | 0.7915 | 0.7843 |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 173.00 | 117.50 | 1.4723 | 1.4156 | |
| BT-20 | 0 | uM | 7 | 156.25 | 28.40 | 3.00 | 117.50 | 0.0255 | -0.6661 | |
| BT-20 | 0 | uM | 7 | 312.50 | 133.67 | 2.00 | 285.50 | 0.0070 | -0.9785 |